insights_auto
Why is ALNY down 6.31%?
Dive Deeperchevron_right
ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
$ 231.18
arrow_downward
-6.31%(-15.56) 1D
$ 231.18
0.00% (0.00)
bedtimeAfter hours
Closed: 10-р сарын 1, 16:00:01 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNY...
Open
$ 248.21
High
$ 251.71
Low
$ 230.06
Mkt. cap
30.93 тэрбум
Avg. vol.
1.54 сая
Volume
0.00
P/E ratio
39.35
52-wk high
$ 495.55
52-wk low
$ 197.81
EPS
$ 5.88
Beta
0.31
Shares outstanding
133.81 сая
No. of employees
2 мян
Open
$ 248.21
High
$ 251.71
Low
$ 230.06
Mkt. cap
30.93 тэрбум
Avg. vol.
1.54 сая
Volume
0.00
P/E ratio
39.35
52-wk high
$ 495.55
52-wk low
$ 197.81
EPS
$ 5.88
Beta
0.31
Shares outstanding
133.81 сая
No. of employees
2 мян
News stories
From web sources and news partners
Benzinga
·
12 цагийн өмнө
Stock Market Today: S&P 500 Slips as Micron Fails to Impress, 10-Year Yields Ease to 5.25%
Benzinga
·
12 цагийн өмнө
Here's How Much $100 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth Today
TipRanks
·
13 цагийн өмнө
Alnylam Stock Sinks as Wall Street Turns Cautious
GuruFocus
·
1 өдрийн өмнө
ALNY Maintains by JP Morgan -- Price Target Lowered to $369
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals, Inc.